Ligand Pharmaceuticals LGND Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's change in inventories?
- Ligand Pharmaceuticals (LGND) reported change in inventories of $4.14M in Q1 2026.
- How has Ligand Pharmaceuticals's change in inventories changed year-over-year?
- Ligand Pharmaceuticals's change in inventories increased by 728.0% year-over-year, from $500K to $4.14M.
- What is the long-term trend for Ligand Pharmaceuticals's change in inventories?
- Over 3 years (2022 to 2025), Ligand Pharmaceuticals's change in inventories has grown at a -25.5% compound annual growth rate (CAGR), from -$12.06M to -$4.99M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.